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Mechanisms of Action of Okadaic Acid
Class Tumor Promoters on Mouse Skin
by Hirota Fujiki,* Masami Suganuma,* Seiji Yoshizawa,*
Shinji Nishiwaki,* Boonsong Winyar,* and Takashi
Sugimurat
Okadaic acid, dinophysistoxin-1 (35-methylokadaic acid), and calyculin A are the okadaic acid class of
non-12-O-tetradecanoylphorbol-13-acetate (TPA)-type tumor promoters, which do not bind to the phorbol
ester receptors in cell membranes or activate protein kinase C in vitro. They have potent tumor-promoting
activities on mouseskin, as strongasTPA-type tumorpromoters, such asTPA, teleocidin, andaplysiatoxin.
DNA samples isolated from tumors induced by dimethylbenz[a]anthracene and each of the okadaic acid
class tumor promoters had the same mutation at the second nucleotide of codon 61 (CAA to CTA) in the
c-H-ras gene. Okadaic acid receptors, protein phosphatases 1 and 2A, are present in the particulate as
well as cytosolic fractions of various mouse tissues. The apparent "activation" of protein kinases by the
okadaic acid class tumor promoters, after their incubation with 32P-ATP, protein kinases, and protein
phosphatases, was observed. This activation was caused by inhibition of protein phosphatases 1 and 2A
by the okadaic acid class tumor promoters. Treatment of primary human fibroblasts and human keratin-
ocytes with the okadaic acid class tumor promoters induced the hyperphosphorylation ofa 60-kDa protein
in nuclear and cytosolic fractions, due to the inhibition of protein phosphatases. The 60-kDa protein is a
proteolytic fragment ofnucleolin, amajornonhistone protein and isdesignated as "N-60."Themechanisms
of action of the okadaic acid class tumor promoters are discussed with emphasis on the inhibition of
protein phosphatase activity.
Introduction
The aim of our research on tumor promotion is to find
new tumor promoters on mouse skin and to understand
the mechanisms ofaction oftumor promoters, the struc-
tures of which are varied. Based on these studies, we
would like to clarify the process of tumor promotion
that might take place in human cancer cells (1).
So far we have found 25 new tumor promoters that
are structurally different from 12-0-tetradecanoylphor-
bol-13-acetate (TPA). These newtumorpromoters were
classified into TPA-type tumor promoters and non-TPA
type tumor promoters, depending on their ability to
bind to the phorbol ester receptors. TPA-type tumor
promoters act through the activation of protein kinase
C, whereas non-TPA type tumor promoters do not me-
diate through protein kinase C (2).
Sincethetumor-promotingactivityoftheokadaicacid
class compounds is as strong as TPA, teleocidin, and
aplysiatoxin, and the strongest of the other non-TPA
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type tumor promoters, such as palytoxin, thapsigargin,
and staurosporine (3,4), we started to study how the
okadaic acid class tumor promoters act on cells (5-7).
We called the okadaic acid class tumor promoters those
whichbound tothe okadaicacidreceptors, proteinphos-
phatases 1 and 2A (1).
Okadaic Acid Class Tumor
Promoters
Okadaic acid, dinophysistoxin-1 (35-methylokadaic
acid), and calyculin A are the new okadaic acid class
tumor promoters (Fig. 1). Okadaic acid and dinophys-
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FIGURE 1. Structures of the okadaic acid class tumor promoters,
okadaic acid, dinophysistoxin-1, and calyculin A.FUJIKI ET AL.
istoxin-1 were both isolated from a black sponge, Hal-
ichondria okadai (8). Dinophysistoxin-1 was first iso-
lated from the hepatopancreas of the mussel, as a
causative agentofdiarrhetic shellfishpoisoninginJapan
(9). Calyculin A was isolated from a sponge, Disco-
dermia calyx (10). Although calyculin A is structurally
unrelated to okadaic acid, calyculin A bound to the oka-
daic acid receptors.
Table 1 shows tumor-promoting activity ofthe three
okadaic acid class tumor promoters, okadaic acid, di-
nophysistoxin-1, and calyculin A. From 1 week after
initiation with a single application of 100 ,ug of 7,12-
dimethylbenz[a]anthracene (DMBA), 1 ,ug ofeach com-
pound ofthe okadaic acid class was applied to the skin
of the back of mice, twice a week. Okadaic acid, dino-
physistoxin-1, and calyculin A gave similarly high per-
centages of tumor-bearing mice and also high average
numbers of tumors per mouse, which were similar to
results with the most potent TPA-type tumor pro-
moters. These data indicated that a potent tumor-pro-
moting activity could be achieved by the okadaic acid
receptors as well as by the phorbol ester receptors.
In collaboration with I. B. Weinstein's group at Co-
lumbia University and S. Manam at Merck Sharp &
Dohme Research Laboratories, we studied the activa-
tion of c-H-ras gene in tumors. DNA samples isolated
from tumors of the three groups treated with DMBA
plus each tumor promoter ofthe okadaic acid class were
analyzed by polymerase chain reaction procedure and
DNA sequencing. The mutation of CAA to CTA was
found in codon 61 of mouse c-H-ras gene in the DNA
samples (11). The same mutation of c-H-ras gene was
reported in mouse skin tumorstreated with DMBAplus
TPA, teleocidin, aplysiatoxin, chrisarobin, mezerein,
and benzoylperoxide (11-13). Thus, hypermutability of
codon 61 ofc-H-ras gene is anessential feature in atwo-
stage carcinogenesis experiment on mouse skin.
Okadaic Acid Receptors
Because the potency of tumor-promoting activity of
the okadaic acid class was comparable to that of the
TPA-type tumor promoters, we thought that okadaic
acid might bind to a specific receptor (5). Figure 2 dem-
onstrates the specific 3H-okadaic acid binding to the
particulate fraction of mouse skin. This specific 3H-oka-
daic acid binding was inhibited by okadaic acid, dino-
physistoxin-1, and calyculin A, but not by okadaic acid
tetramethyl ether, an inactive compound (data not
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FIGURE 2. Specific bindingof3H-okadaic acid totheparticulate frac-
tion of mouse skin. (A) With 80 nM 3H-okadaic acid; (B) with 200
,ug protein ofthe particulate fraction. (TB, 0) total binding; (SB,
0) specific binding; (NSB, X) nonspecific binding.
shown). Since this specific 3H-okadaic acid binding was
not inhibited by TPA, teleocidin, aplysiatoxin, paly-
toxin, or thapsigargin, okadaic acid class tumor pro-
moters were thought to bind to their own receptors.
The okadaic acid receptors were also found in the cy-
tosolic fraction of mouse skin. Although the conditions
of the binding assays of 3H-okadaic acid to the partic-
ulate and cytosolic fractions were not the same, the KD
value of 3H-okadaic acid of the cytosolic fraction was
about 10 times higher than that ofthe particulate frac-
tion (5).
To better understand the biochemical nature of oka-
daic acid receptors inthecytosolicfraction, the cytosolic
fraction of mouse epidermis and mouse brain were sub-
jected to DEAE-cellulose column chromatography. The
specific 'H-okadaic acid binding fraction from both the
cytosolic fractions, which was eluted with 0.2 M NaCl,
containedproteinphosphatases and proteinkinases, the
latter ofwhich were distinct from protein kinase C (6).
Okadaic acid bound to purified protein phosphatases 1
and 2A (5,6), which catalyze the dephosphorylation of
phosphoserine and phosphothreonine ofproteins and in-
hibited protein phosphatase activities (14-16).
Recently, we have demonstrated that a photoaffinity
probe of okadaic acid covalently bound to a catalytic
Table 1. Tumor-promoting activities of the okadaic acid class compared with those ofTPA-type tumor promoters.
Amount of compound/ Maximal percentage oftumor- Average numbers oftumors/
Promoter application, ,ug (nmole) bearing mice mouse in week 30
Okadaic acid 1.0 (1.2) 86.7 7.2
Dinophysistoxin-1 1.0 (1.2) 100.0 8.5
Calyculin A 1.0 (1.0) 93.3 4.3
TPA 2.5 (4.1) 100.0 11.0
Teleocidin 2.5 (5.7) 100.0 4.0
Aplysiatoxin 2.5 (4.0) 80.0 3.4
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FIGURE 3. Mechanisms ofaction ofthe TPA-type tumor promoters
and the okadaic acid class tumor promoters.
subunit of protein phosphatase 2A (Fujiki et al., un-
published results). With 2P-ATP, the incubation ofpro-
tein phosphatases and protein kinases, which are both
contained in the binding fraction, achieved a 3-fold ac-
tivation of protein kinase activity by okadaic acid (6).
From these results, we understood that inhibition of
protein phosphatases by okadaic acid resulted in the
apparent"activation" ofprotein kinases because okadaic
acid itselfdid not cause any direct effect on the activity
of protein kinases (6,7).
As for the target proteins from the apparent "acti-
vation" of protein kinases by okadaic acid in the cells,
we had previously reported that okadaic acid induced a
hyperphosphorylation of a 60-kDa protein in primary
human fibroblasts (17). This hyperphosphorylation ofa
60-kDa protein (N-60) was also found in human kera-
tinocytes immortalized by human papilloma virus DNA
by treatment with the okadaic acid class tumor pro-
moters (data not shown). A hyperphosphorylated N-60,
which might be short-lived, becomes a long-lived pro-
tein by inhibition of protein phosphatases by okadaic
acid. Subsequently, the remaining hyperphosphory-
lated N-60 is probably involved in the clonal expansion
of the initiated cells (1,7,11).
The mechanisms of action of the okadaic acid class
tumorpromoters are compared to TPA-type tumorpro-
moters (Fig. 3). Okadaic acid inhibits protein phospha-
tases and accumulates the phosphorylated proteins in
largeramountsthanintheusualstate, whichisreflected
asthe apparent "activation" ofproteinkinases. The oka-
daic acid class tumor promoters open up a new under-
standing of the mechanisms of tumor promotion on
mouse skin.
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